Kandeel, Amr
Moatasim, Yassmin
Fahim, Manal
Bahaaeldin, Hala
El-Shesheny, Rabeh
Roshdy, Wael H.
Kamel, Mina N.
Shawky, Shaymaa
Gomaa, Mokhtar
Naguib, Amel
Guindy, Nancy El
Deghedy, Ola
Kamel, Reham
Khalifa, Mohamed
Galal, Ramy
Hassany, Mohamed
Mahmoud, Galal
Kandeil, Ahmed
Afifi, Salma
Mohsen, Amira
Fattah, Mohammad Abdel
Kayali, Ghazi
Ali, Mohamed A.
Abdelghaffar, Khaled
Funding for this research was provided by:
Ministry of Health and Population
Article History
Received: 23 April 2023
Accepted: 10 August 2023
First Online: 18 August 2023
Declarations
:
: The study was approved by the Ministry of Health and Population Ethics committee and institutional review board (IRB). All methods were carried out in accordance with MoHP/IRB guidelines and regulations.
: The study was approved by the Egyptian Ministry of Health and Population (MoHP) Institutional Review Board (IRB). Waiver of informed consent was granted by MoHP IRB as the study used secondary data generated out of a surveillance system and specimens were collected as a part of the usual patients’ clinical management procedures. All samples were deidentified for the genotyping study purposes in accordance with MoHP/IRB guidelines and regulations.
: NA.
: The authors declare no competing interests.